COMPOSITION PHARMACEUTIQUE POUR LA PRÉVENTION ET LE TRAITEMENT DE LA STÉATOHÉPATITE NON ALCOOLIQUE, DE LA FIBROSE HÉPATIQUE ET DE LA CIRRHOSE DU FOIE, COMPRENANT DES DÉRIVÉS D'ADÉNOSINE

摘要

A pharmaceutical composition for preventing or treating liver disease is provided. The pharmaceutical composition comprising a compound represented by formula 1 below or a pharmaceutically acceptable salt of the compound as an active ingredient:where A is S, R is a linear or branched C-Calkyl which is non-substituted or is independently or selectively substituted with one or more C-Caryl groups, a benzyl which is non-substituted or is independently or selectively substituted with halogen or one or more linear or branched C-Calkoxy groups, or a hydroxycarbonyl-substituted benzyl, and Y is H or a halogen atom.